| Ytd | -65.65% | |
| 1y | -10.43% |
| Open | 5.81 | Prev Close | 5.81 | Low | 5.79 | High | 5.99 | Mkt Cap | 1.12B |
| Vol | 3.12M | Avg Vol | 3.79M | EPS | -1.05 | P/E | N/A | Forward P/E | -5.39 |
| Beta | -1.33 | Short Ratio | 4.92 | Inst. Own | 82.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 6.45 | 200-d Avg | 9.72 | 1yr Est | 21.94 |
The consensus price target hints at a 294.7% upside potential for Wave Life Sciences (WVE). While em
In Phase 1 portion of trial, WVE-007 improved body composition by inducing fat loss, including harmf